L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own CRNX

Crinetics Pharmaceuticals In in the Q2 2026 filings. At least 1 of the 91 current managers on file reported a position, worth $336m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.

Managers holding
1
at least, of 91 current
Combined value
$336m
as reported
Opened
0
new this quarter
Added to
1
already held
Trimmed or sold out
0
0 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
Farallon Capital Management LLC
Long/short equity · $21.7bn book
$336m1.6%8,989,098+$34m+651,000Added

Ownership through time

At least 6 of the 95 managers whose filings are on file listed CRNX in Q2 2026, against 1 in Q3 2018. 1 manager more than in Q1 2026: 1 listed it again.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
047Q3 2018: 1Q4 2018: 1Q2 2020: 1Q3 2020: 1Q4 2020: 1Q1 2021: 121Q2 2021: 1Q4 2021: 2Q1 2022: 222Q2 2022: 2Q3 2022: 2Q4 2022: 2Q1 2023: 123Q2 2023: 1Q3 2023: 5Q4 2023: 4Q1 2024: 624Q2 2024: 7Q3 2024: 6Q4 2024: 6Q1 2025: 625Q2 2025: 5Q3 2025: 7Q4 2025: 7Q1 2026: 526Q2 2026: 6
  • Q3 2018: 1
  • Q4 2018: 1
  • Q2 2020: 1
  • Q3 2020: 1
  • Q4 2020: 1
  • Q1 2021: 1
  • Q2 2021: 1
  • Q4 2021: 2
  • Q1 2022: 2
  • Q2 2022: 2
  • Q3 2022: 2
  • Q4 2022: 2
  • Q1 2023: 1
  • Q2 2023: 1
  • Q3 2023: 5
  • Q4 2023: 4
  • Q1 2024: 6
  • Q2 2024: 7
  • Q3 2024: 6
  • Q4 2024: 6
  • Q1 2025: 6
  • Q2 2025: 5
  • Q3 2025: 7
  • Q4 2025: 7
  • Q1 2026: 5
  • Q2 2026: 6
Their combined reported value
$0$961m$2bnQ3 2018: $4.1mQ4 2018: $2.9mQ2 2020: $6.9mQ3 2020: $8.0mQ4 2020: $17mQ1 2021: $19m21Q2 2021: $13mQ4 2021: $34mQ1 2022: $31m22Q2 2022: $28mQ3 2022: $31mQ4 2022: $32mQ1 2023: $7.0m23Q2 2023: $308kQ3 2023: $162mQ4 2023: $136mQ1 2024: $650m24Q2 2024: $696mQ3 2024: $807mQ4 2024: $1.1bnQ1 2025: $1.2bn25Q2 2025: $617mQ3 2025: $1.6bnQ4 2025: $1.9bnQ1 2026: $1.5bn26Q2 2026: $1.6bn
  • Q3 2018: $4.1m
  • Q4 2018: $2.9m
  • Q2 2020: $6.9m
  • Q3 2020: $8.0m
  • Q4 2020: $17m
  • Q1 2021: $19m
  • Q2 2021: $13m
  • Q4 2021: $34m
  • Q1 2022: $31m
  • Q2 2022: $28m
  • Q3 2022: $31m
  • Q4 2022: $32m
  • Q1 2023: $7.0m
  • Q2 2023: $308k
  • Q3 2023: $162m
  • Q4 2023: $136m
  • Q1 2024: $650m
  • Q2 2024: $696m
  • Q3 2024: $807m
  • Q4 2024: $1.1bn
  • Q1 2025: $1.2bn
  • Q2 2025: $617m
  • Q3 2025: $1.6bn
  • Q4 2025: $1.9bn
  • Q1 2026: $1.5bn
  • Q2 2026: $1.6bn

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Started in Q2 2026

No manager on file started a position.

Largest increases, by shares

Largest decreases, by shares

Left it

No manager on file is shown leaving it.

ManagerValue over timeFirst listedLargestQ2 2026
Fidelity (FMR LLC)Q1 2025$665m$593m
Farallon Capital Management LLCQ3 2018$336m$336m
Wellington Management Group LLPQ1 2024$374m$267m
T. Rowe Price Associates IncQ1 2024$277m$232m
Janus Henderson Group LtdQ1 2024$207m$171m
Marshall Wace LLPQ2 2026$42m$42m
Point72 Asset Management LPQ2 2020$232mlast listed Q4 2025
Schonfeld Strategic Advisors LLCQ3 2023$29mlast listed Q4 2024
Walleye Capital LLCQ4 2021$13mlast listed Q3 2023
Woodline Partners LPQ3 2023$7.2mlast listed Q1 2024
ExodusPoint Capital Management LPQ4 2023$5.2mlast listed Q2 2024
Winton Group LtdQ3 2025$2.8mlast listed Q4 2025
Moore Capital Management LPQ2 2023$308klast listed Q2 2023

What CRNX is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around CRNX →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.